Exozymes Inc (EXOZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,039 | 5,099 | 6,986 | 8,512 | 9,719 |
| Receivables | 517 | 303 | 257 | 595 | 737 |
| TOTAL | $3,940 | $5,606 | $7,531 | $9,419 | $10,820 |
| Non-Current Assets | |||||
| PPE Net | 764 | 763 | 821 | 843 | 882 |
| Other Non-Current Assets | 1,268 | 1,350 | 1,325 | 1,264 | 1,332 |
| TOTAL | $2,032 | $2,113 | $2,146 | $2,107 | $2,214 |
| Total Assets | $5,972 | $7,719 | $9,677 | $11,526 | $13,034 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,241 | 922 | 931 | 1,208 | 1,103 |
| TOTAL | $1,567 | $1,238 | $1,217 | $1,444 | $1,333 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 853 | 927 | 1,021 | 1,090 | 1,157 |
| TOTAL | $1,007 | $1,106 | $1,224 | $1,200 | $1,280 |
| Total Liabilities | $2,574 | $2,345 | $2,441 | $2,644 | $2,614 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,479 | 8,387 | 8,387 | 8,368 | 8,368 |
| Retained earnings | -21,105 | -18,450 | -16,163 | -13,802 | -11,946 |
| TOTAL | $3,397 | $5,374 | $7,236 | $8,882 | $10,421 |
| Total Liabilities And Equity | $5,972 | $7,719 | $9,677 | $11,526 | $13,034 |